Kilitch Drugs surges on making additional investment in Kilitch Estro Biotech PLC

22 Jan 2025 Evaluate

Kilitch Drugs (India) is currently trading at Rs. 339.20, up by 2.20 points or 0.65% from its previous closing of Rs. 337.00 on the BSE.

The scrip opened at Rs. 345.55 and has touched a high and low of Rs. 349.20 and Rs. 336.85 respectively. So far 184 shares were traded on the counter.

The BSE group 'B' stock of face value Rs. 10 has touched a 52 week high of Rs. 469.85 on 08-Feb-2024 and a 52 week low of Rs. 298.45 on 29-Oct-2024.

Last one week high and low of the scrip stood at Rs. 355.20 and Rs. 326.60 respectively. The current market cap of the company is Rs. 545.51 crore.

The promoters holding in the company stood at 69.23%, while Non-Institutions held 30.77% stake in the company.

Kilitch Drugs (India) has made additional investment of $2,00,000 to acquire equity shares of Kilitch Estro Biotech PLC, foreign subsidiary of the Company to enhance investment of Kilitch Drugs (India) for long term return of investment and to meet fund requirement of the subsidiary. 

Kilitch Estro Biotech PLC is engaged in manufacturing of Pharmaceutical Products incorporated in September, 2015 in Ethiopia, commenced its production in January, 2022. 

Kilitch Drugs (India) is an India-based company engaged in pharmaceutical business. The company’s services range from manufacturing to marketing a host of formulations in all dosage forms, such as solid, liquid and parenteral forms.


Kilitch Drugs(India) Share Price

361.45 17.45 (5.07%)
28-Mar-2025 16:59 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1735.45
Dr. Reddys Lab 1144.05
Cipla 1441.70
Lupin 2026.50
Zydus Lifesciences 885.70
View more..
© 2025 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt. Ltd.
Please wait your portfolio is updating...